Impact of immunosuppressive therapy on hepatitis C infection after renal transplantation.

@article{Kahraman2011ImpactOI,
  title={Impact of immunosuppressive therapy on hepatitis C infection after renal transplantation.},
  author={Alisan Kahraman and Oliver Witzke and Andre. Scherag and Carolin Puetter and Michael Miller and Alexander D{\^e}chene and Susan R Ross and Guido G H Gerken and Phillip Hilgard},
  journal={Clinical nephrology},
  year={2011},
  volume={75 1},
  pages={16-25}
}
BACKGROUND Among patients after renal transplantation (NTx), hepatitis C virus (HCV) infection is a risk factor for graft loss and patient death caused by hepatic decompensation. Also, HCV has been implicated in the pathogenesis of glomerular diseases in native and transplanted kidneys. Therefore, the aim of this retrospective cohort study was to determine the effects of the widely used calcineurin inhibitors (CNI) cyclosporine A (CsA) and tacrolimus (Tac) on hepatitis C virus replication… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients.

Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia • 2018
View 5 Excerpts
Highly Influenced

Hepatitis C and renal transplantation.

Current opinion in organ transplantation • 2012

Similar Papers

Loading similar papers…